ALBENDAZOLE MIGHT PROVIDE IMPROVED CONTROL OF HYDATID DISEASE Newsletter Article 14 February 2013 Pages: 2 - 2
A CAUTIONARY APPROACH TO THE USE OF CYTOTOXIC DRUGS FOR NON-MALIGNANCY Newsletter Article 14 February 2013 Pages: 3 - 3
ARE STEROIDS RESPONSIBLE FOR INCREASED INCIDENCE OF PEPTIC ULCERS? Newsletter Article 14 February 2013 Pages: 4 - 5
THYMOSTIMULIN: boosting age-related immunodepression Newsletter Article 14 February 2013 Pages: 5 - 5
OMEPRAZOLE: profound reduction of gastric acid secretion Newsletter Article 14 February 2013 Pages: 6 - 6
MAINTENANCE CIMETIDINE IS USEFUL IN PREVENTING ULCER RELAPSE Newsletter Article 14 February 2013 Pages: 7 - 7
MEGESTROL AS AN ALTERNATIVE THERAPY FOR ENDOMETRIAL HYPERPLASIA Newsletter Article 14 February 2013 Pages: 8 - 9
AGE DOES NOT SEEM TO LIMIT THE BENEFITS OF GOLD THERAPY Newsletter Article 14 February 2013 Pages: 9 - 9
CIMETIDINE FOR HYPERIMMUNOGL OBULINE RECURRENT INFECTION SYNDROME Newsletter Article 14 February 2013 Pages: 10 - 11
INOSIPLEX PROVES DISAPPOINTING IN RECURRENT HSV INFECTIONS Newsletter Article 14 February 2013 Pages: 11 - 11
INVESTIGATION INTO THE SPECTRUM OF USES FOR CEPHALOSPORINS CONTINUES Newsletter Article 14 February 2013 Pages: 12 - 12
NEW USE FOR PHENYTOIN? TOPICAL TREATMENT OF SOFT TISSUE ULCERS Newsletter Article 14 February 2013 Pages: 12 - 13
TAILORING DRUG REGIMENS FOR PATIENTS WITH RENAL IMPAIRMENT Newsletter Article 14 February 2013 Pages: 13 - 13
CLAVULANIC ACID DOES NOT SEEM TO AFFECT THE KINETICS OF TICARCILLIN Newsletter Article 14 February 2013 Pages: 14 - 14
CIRCADIAN CHANGES ALTER THE KINETICS OF SLOW RELEASE INDOMETHACIN Newsletter Article 14 February 2013 Pages: 15 - 15
CHLORPHENIRAMINE SPRAY INHIBITS HISTAMINE-INDUCED NASAL SYMPTOMS Newsletter Article 14 February 2013 Pages: 15 - 15
RANITIDINE INCREASES THE BIOAVAILABILITY OF MIDAZOLAM Newsletter Article 14 February 2013 Pages: 15 - 15
CHLOROQUINE: STEADY-STATE KINETICS IN PATIENTS WITH RHEUMATOID DISEASE Newsletter Article 14 February 2013 Pages: 16 - 16
BETAXOLOL: world first introduction of this cardioselective β-blocker by Robert et Carriere in France (continued) Newsletter Article 14 February 2013 Pages: 19 - 19
CEFMENOXIME: third generation cephalosporin recently marketed in Japan by Takeda and in Germany by Grunenthal Newsletter Article 14 February 2013 Pages: 19 - 20